Tectonic Therapeutic (TECX) Other Non-Current Liabilities (2017 - 2025)
Tectonic Therapeutic's (TECX) quarterly Other Non-Current Liabilities came in at $0.1 in Q4 2025, down 100.0% on a QoQ basis from $371000.0 in Q4 2017.
Tectonic Therapeutic (TECX) Other Non-Current Liabilities (2017 - 2025) Analysis & Trends
Tectonic Therapeutic (TECX) has 2 years of Other Non-Current Liabilities data on file, last reported at $0.1 in Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $0.1 in Q4 2025; TTM through Dec 2025 was $0.1, a N/A change from a year earlier, with the FY2025 full-year figure at $0.1, changed N/A from the prior year.
- Other Non-Current Liabilities for Q4 2025 stood at $0.1, down from $371000.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for TECX reached as high as $0.1 in Q4 2025 and fell as low as $0.1 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.10 |
| Dec 31, 2017 | 371,000.00 |